Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 58

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 58
---
. NewGenIvf’s shareholders should not rely on its revenue
for any prior quarterly or annual periods as any indication of its future revenue or revenue growth.

In addition, NewGenIvf expects
to continue to expend substantial financial and other resources on:

| ● | sales and marketing; |

| ● | technology infrastructure, including systems architecture, scalability, availability, performance and security; and |

| ● | general administration, including increased legal and accounting expenses associated with being a public company. |

These investments may not
result in increased revenue growth in its business. If NewGenIvf is unable to increase its revenue at a rate sufficient to offset the
expected increase in its costs, its business, financial position, and results of operations will be harmed, and NewGenIvf may not be able
to maintain profitability over the long term. Additionally, NewGenIvf may encounter unforeseen operating expenses, difficulties, complications,
delays and other unknown factors that may result in losses in future periods.

If its revenue growth does
not meet its expectations in future periods, NewGenIvf may not maintain profitability in the future, its business, financial position
and results of operations may be harmed.

NewGenIvf’s interim and annual results may fluctuate significantly and may not fully reflect the underlying performance of NewGenIvf’s business.

NewGenIvf’s
interim and annual results of operations, including the levels of NewGenIvf’s revenues, expenses, net (loss)/income and other
key metrics, may vary significantly in the future due to a variety of factors, some of which are outside of NewGenIvf’s
control, and period-to-period comparisons of NewGenIvf’s operating results may not be meaningful, especially given
NewGenIvf’s limited operating history. Accordingly, the results for any one fiscal half year or any one fiscal year are not
necessarily an indication of future performance. Fluctuations in interim and/or annual financial results may adversely affect the
price of NewGenIvf’s ordinary shares. Factors that may cause fluctuations in NewGenIvf’s interim and annual financial
results include:

| ● | NewGenIvf’s ability to attract new customers and maintain relationships with existing customers; |

<div align='center'>33</div>

| ● | changes in NewGenIvf’s products and services offered and introduction of new services and products; |

| ● | the amount and timing of operating expenses related to marketing and the maintenance and expansion of NewGenI